Senage Thomas, Gerrard Caroline, Moorjani Narain, Jenkins David P, Ali Jason M
Department of Cardiothoracic Surgery, Royal Papworth Hospital, Cambridge, UK.
SPHERE (MethodS in Patient-Centred Outcomes and Health Research), University of Nantes, Nantes, France.
J Thorac Dis. 2021 Oct;13(10):5670-5682. doi: 10.21037/jtd-21-1241.
Significant bleeding following cardiac surgery is a recognised complication, associated with a requirement for re-exploration and blood transfusion, both associated with increased morbidity and early mortality. The aim of this study was to examine the impact of the volume of early postoperative bleeding on long-term survival for patients undergoing coronary artery bypass grafting (CABG).
A retrospective analysis was performed of patients undergoing first-time isolated CABG at a single centre between January 2003 and April 2013, conditional from 30-day survival.
Six thousand two hundred and sixty-five patients were analysed, with a mean Logistic EuroSCORE of 4.9%. The mean age was 67.8 years. Median follow-up was 11.5 years. The overall 10- and 15-year survival was 70.6% and 51.9% respectively. Following surgery, 4.6% (n=291) required return to theatre for re-exploration, and 43.6% (n=2,733) received at least one red cell transfusion. In multivariable analysis, the strongest correlates of mortality were age, smoking history, BMI, COPD, renal impairment, preoperative left ventricular function and preoperative haemoglobin (Hb) level. Twelve-hour blood loss was an additional predictor of inferior long-term survival. Five-year survival was 89.6% for patients with <500 mL blood loss, 86.8% for 500-1,000 mL and 83.8% for >1,000 mL. Re-exploration and receiving blood transfusion were not associated with reduced long-term survival.
Significant 12-hour blood loss is associated with inferior long-term survival following CABG. This observation supports efforts aimed at improving intra-operative haemostasis and aggressive management of patients with early signs of bleeding.
心脏手术后严重出血是一种公认的并发症,与再次手术探查及输血需求相关,二者均与发病率增加和早期死亡率相关。本研究的目的是探讨冠状动脉旁路移植术(CABG)患者术后早期出血量对长期生存的影响。
对2003年1月至2013年4月在单一中心接受首次单纯CABG手术且生存30天以上的患者进行回顾性分析。
共分析了6265例患者,平均逻辑欧洲心脏手术风险评估系统(Logistic EuroSCORE)为4.9%。平均年龄为67.8岁。中位随访时间为11.5年。总体10年和15年生存率分别为70.6%和51.9%。术后,4.6%(n = 291)的患者需要返回手术室进行再次探查,43.6%(n = 2733)的患者接受了至少一次红细胞输血。在多变量分析中,死亡率最强的相关因素是年龄、吸烟史、体重指数、慢性阻塞性肺疾病、肾功能损害、术前左心室功能和术前血红蛋白(Hb)水平。术后12小时失血量是长期生存较差的另一个预测因素。失血量<500 mL的患者5年生存率为89.6%,500 - 1000 mL的患者为86.8%,>1000 mL的患者为83.8%。再次探查和接受输血与长期生存率降低无关。
CABG术后12小时严重失血与长期生存较差相关。这一观察结果支持旨在改善术中止血以及对有早期出血迹象患者进行积极管理的努力。